Basics |
Korro Bio, Inc.
|
IPO Date: |
October 4, 2019 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$129.59M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.92 | 4.37%
|
Avg Daily Range (30 D): |
$1.03 | 6.44%
|
Avg Daily Range (90 D): |
$1.12 | 5.36%
|
Institutional Daily Volume |
Avg Daily Volume: |
.3M |
Avg Daily Volume (30 D): |
.08M |
Avg Daily Volume (90 D): |
.07M |
Trade Size |
Avg Trade Size (Sh.): |
136 |
Avg Trade Size (Sh.) (30 D): |
52 |
Avg Trade Size (Sh.) (90 D): |
50 |
Institutional Trades |
Total Inst.Trades: |
265 |
Avg Inst. Trade: |
$1.93M |
Avg Inst. Trade (30 D): |
$.61M |
Avg Inst. Trade (90 D): |
$.94M |
Avg Inst. Trade Volume: |
.09M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$2.78M |
Avg Closing Trade (30 D): |
$1.69M |
Avg Closing Trade (90 D): |
$1.69M |
Avg Closing Volume: |
143.32K |
|
|
|
|
Financials |
|
TTM |
Q4 2024 |
FY 2024 |
Basic EPS
|
$-2.49
|
$-2.26
|
$-9.37
|
Diluted EPS
|
$-2.49
|
$-2.26
|
$-9.37
|
Revenue
|
$ 2.55M
|
$ 2.27M
|
$ 2.27M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -23.39M
|
$ -21.2M
|
$ -83.58M
|
Operating Income / Loss
|
$ -25.02M
|
$ -23.04M
|
$ -91.91M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ 8.5M
|
$ -9.33M
|
$ -114.07M
|
PE Ratio
|
|
|
|
|